Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Adverse events with IL-17 and IL-23 inhibitors for psoriasis and psoriatic arthritis: a systematic review and meta-analysis of phase III studies.

Loft ND, Vaengebjerg S, Halling-Sønderby AS, Skov L, Egeberg A.

J Eur Acad Dermatol Venereol. 2019 Nov 13. doi: 10.1111/jdv.16073. [Epub ahead of print] Review.

PMID:
31721310
2.

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.

Warren RB, See K, Burge R, Zhang Y, Brnabic A, Gallo G, Garrelts A, Egeberg A.

Dermatol Ther (Heidelb). 2019 Nov 4. doi: 10.1007/s13555-019-00337-y. [Epub ahead of print]

PMID:
31686337
3.

The Association Between Season of Birth and Atopic Dermatitis in the Northern Hemisphere: A Systematic Review and Meta-Analysis.

Calov M, Alinaghi F, Hamann CR, Silverberg J, Egeberg A, Thyssen JP.

J Allergy Clin Immunol Pract. 2019 Oct 31. pii: S2213-2198(19)30896-7. doi: 10.1016/j.jaip.2019.10.007. [Epub ahead of print]

PMID:
31678290
4.

Clinical characteristics, symptoms, and burden of psoriasis and atopic dermatitis in adults.

Egeberg A, Griffiths CEM, Williams HC, Andersen YMF, Thyssen JP.

Br J Dermatol. 2019 Oct 20. doi: 10.1111/bjd.18622. [Epub ahead of print]

PMID:
31630393
5.

Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study.

Loft ND, Egeberg A, Rasmussen MK, Bryld LE, Gniadecki R, Dam TN, Iversen L, Skov L.

Acta Derm Venereol. 2019 Oct 3. doi: 10.2340/00015555-3331. [Epub ahead of print]

6.

Use of topical calcipotriol for identification of patients with psoriasis in administrative healthcare data-a validation study.

Egeberg A, Andersen YMF.

J Eur Acad Dermatol Venereol. 2019 Oct 1. doi: 10.1111/jdv.15991. [Epub ahead of print] No abstract available.

PMID:
31574175
7.

Pain severity and use of analgesic medication in adults with atopic dermatitis: a cross-sectional study.

Thyssen JP, Halling-Sønderby AS, Wu JJ, Egeberg A.

Br J Dermatol. 2019 Sep 25. doi: 10.1111/bjd.18557. [Epub ahead of print]

PMID:
31556099
8.

Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease - A systematic review and meta-analysis.

Alinaghi F, Tekin HG, Burisch J, Wu JJ, Thyssen JP, Egeberg A.

J Crohns Colitis. 2019 Aug 30. pii: jjz152. doi: 10.1093/ecco-jcc/jjz152. [Epub ahead of print]

PMID:
31504363
9.

Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis.

Egeberg A, Andersen YMF, Halling-Overgaard AS, Alignahi F, Thyssen JP, Burge R, Mallbris L.

J Eur Acad Dermatol Venereol. 2019 Aug 29. doi: 10.1111/jdv.15920. [Epub ahead of print] Review.

PMID:
31465593
10.

Validation of Psoriasis Diagnoses in the Danish National Patient Register

Loft ND, Andersen CH, Halling-Overgaard AS, Thyssen JP, Skov L, Egeberg A.

Acta Derm Venereol. 2019 Aug 9. doi: 10.2340/00015555-3278. [Epub ahead of print] No abstract available.

11.

Seborrhoeic dermatitis - understood or understudied?

Andersen YMF, Egeberg A.

Br J Dermatol. 2019 Oct;181(4):659. doi: 10.1111/bjd.18307. Epub 2019 Jul 30. No abstract available.

PMID:
31361331
12.

Comparing apples, oranges and atopic dermatitis.

Andersen YMF, Egeberg A.

Br J Dermatol. 2019 Jul 25. doi: 10.1111/bjd.18303. [Epub ahead of print] No abstract available.

PMID:
31347145
13.

Lithiumpyridinyl-Driven Synthesis of High-Purity Zero-Valent Iron Nanoparticles and Their Use in Follow-Up Reactions.

Egeberg A, Block T, Janka O, Wenzel O, Gerthsen D, Pöttgen R, Feldmann C.

Small. 2019 Sep;15(37):e1902321. doi: 10.1002/smll.201902321. Epub 2019 Jul 22.

PMID:
31328863
14.

In Psoriatic Arthritis fatigue is driven by inflammation, disease duration, and chronic pain: An observational DANBIO registry study.

Skougaard M, Jørgensen TS, Rifbjerg-Madsen S, Coates LC, Egeberg A, Amris K, Dreyer L, Højgaard P, Guldberg-Møller J, Merola JF, Frederiksen P, Gudbergsen H, Kristensen LE.

J Rheumatol. 2019 Jul 15. pii: jrheum.181412. doi: 10.3899/jrheum.181412. [Epub ahead of print]

PMID:
31308213
15.

Factors associated with patient-reported importance of skin clearance among adults with psoriasis and atopic dermatitis.

Egeberg A, Thyssen JP.

J Am Acad Dermatol. 2019 Oct;81(4):943-949. doi: 10.1016/j.jaad.2019.06.018. Epub 2019 Jun 13.

PMID:
31202869
16.

The many faces of rosacea: liberal diagnostic criteria have ramifications on disease prevalence and accuracy.

Wienholtz N, Egeberg A, Thyssen JP.

J Eur Acad Dermatol Venereol. 2019 Nov;33(11):e426-e427. doi: 10.1111/jdv.15748. Epub 2019 Jul 1. No abstract available.

PMID:
31199527
17.

Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis.

Egeberg A, Bryld LE, Skov L.

J Am Acad Dermatol. 2019 Jun 3. pii: S0190-9622(19)30886-2. doi: 10.1016/j.jaad.2019.05.082. [Epub ahead of print] No abstract available.

PMID:
31170436
18.

Anti-TNF biosimilars in psoriasis: from scientific evidence to real-world experience.

Barker J, Girolomoni G, Egeberg A, Goncalves J, Pieper B, Kang T.

J Dermatolog Treat. 2019 May 16:1-7. doi: 10.1080/09546634.2019.1610553. [Epub ahead of print]

PMID:
31094242
19.

Risk for appendicitis, cholecystitis, or diverticulitis in patients with psoriasis.

Lee EB, Amin M, Duan L, Egeberg A, Wu JJ.

Cutis. 2019 Mar;103(3):175-179;E1;E2.

PMID:
31039227
20.

Chronic urticaria - bad to the bone?

Egeberg A.

Br J Dermatol. 2019 May;180(5):979. doi: 10.1111/bjd.17760. No abstract available.

PMID:
31025726
21.

Chronologic order of appearance of immune-mediated inflammatory diseases relative to diagnosis of psoriasis.

Andersen YMF, Wu JJ, Thyssen JP, Egeberg A.

J Am Acad Dermatol. 2019 Dec;81(6):1283-1291. doi: 10.1016/j.jaad.2019.04.033. Epub 2019 Apr 19.

PMID:
31009673
22.

Drug survival of guselkumab for psoriasis in a real-world setting: a single-center retrospective chart review.

Lee EB, Reynolds KA, Pithadia DJ, Egeberg A, Wu JJ.

J Dermatolog Treat. 2019 Apr 8:1-2. doi: 10.1080/09546634.2019.1605133. [Epub ahead of print] No abstract available.

PMID:
30957586
23.

Association Between Topical Corticosteroid Use and Type 2 Diabetes in Two European Population-Based Adult Cohorts.

Andersen YMF, Egeberg A, Ban L, Gran S, Williams HC, Francis NA, Knop FK, Gislason GH, Skov L, Thyssen JP.

Diabetes Care. 2019 Jun;42(6):1095-1103. doi: 10.2337/dc18-2158. Epub 2019 Apr 1.

PMID:
30936111
24.

Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.

Burisch J, Jess T, Egeberg A.

Clin Gastroenterol Hepatol. 2019 Mar 29. pii: S1542-3565(19)30305-2. doi: 10.1016/j.cgh.2019.03.040. [Epub ahead of print]

PMID:
30936024
25.

Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis.

Egeberg A, Bryld LE, Skov L.

J Am Acad Dermatol. 2019 Jul;81(1):173-178. doi: 10.1016/j.jaad.2019.03.048. Epub 2019 Mar 23.

PMID:
30914343
26.

Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort.

Egeberg A, Andersen YMF, Thyssen JP.

BMJ Open. 2019 Mar 20;9(3):e028116. doi: 10.1136/bmjopen-2018-028116.

27.

A randomized controlled trial of AMH-based individualized FSH dosing in a GnRH antagonist protocol for IVF.

Friis Petersen J, Løkkegaard E, Andersen LF, Torp K, Egeberg A, Hedegaard L, Nysom D, Nyboe Andersen A.

Hum Reprod Open. 2019 Feb 27;2019(1):hoz003. doi: 10.1093/hropen/hoz003. eCollection 2019.

28.

Burden and Disease Characteristics of Patients with Psoriatic Arthritis: A Population-based Cross-sectional Study.

Tekin HG, Wu JJ, Burge R, Birt J, Egeberg A.

J Rheumatol. 2019 Jul;46(7):716-720. doi: 10.3899/jrheum.180670. Epub 2019 Mar 1.

PMID:
30824662
29.

Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.

Andersen YMF, Augustin M, Petersen J, Hagenström K, Mallbris L, Burge R, Egeberg A.

Br J Dermatol. 2019 Nov;181(5):976-982. doi: 10.1111/bjd.17832. Epub 2019 Jun 2.

PMID:
30815849
30.

Association between parental autoimmune disease and atopic dermatitis in their offspring: a matched case-control study.

Hamann CR, Egeberg A, Silverberg JI, Gislason G, Skov L, Thyssen JP.

J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1143-1151. doi: 10.1111/jdv.15413. Epub 2019 Feb 18.

PMID:
30779234
31.

Real-world drug survival of ixekizumab for psoriasis.

Lee EB, Pithadia DJ, Reynolds KA, Reddy SP, Egeberg A, Wu JJ.

J Am Acad Dermatol. 2019 Jul;81(1):270-272. doi: 10.1016/j.jaad.2019.01.034. Epub 2019 Jan 26. No abstract available.

PMID:
30690047
32.

Demographics, healthcare utilization and drug use in children and adults with atopic dermatitis in Denmark: a population-based cross-sectional study.

Andersen YMF, Egeberg A, Skov L, Thyssen JP.

J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1133-1142. doi: 10.1111/jdv.15424. Epub 2019 Mar 5.

PMID:
30633387
33.

Samarium Polyarsenides Derived from Nanoscale Arsenic.

Schoo C, Bestgen S, Egeberg A, Seibert J, Konchenko SN, Feldmann C, Roesky PW.

Angew Chem Int Ed Engl. 2019 Mar 22;58(13):4386-4389. doi: 10.1002/anie.201813370. Epub 2019 Feb 11.

PMID:
30614173
34.

Exploring the association between parental psychiatric disease and childhood atopic dermatitis: a matched case-control study.

Hamann CR, Egeberg A, Silverberg JI, Gislason G, Skov L, Thyssen JP.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):725-734. doi: 10.1111/jdv.15321. Epub 2018 Nov 25.

PMID:
30383905
35.

Prevalence of contact allergy in the general population: A systematic review and meta-analysis.

Alinaghi F, Bennike NH, Egeberg A, Thyssen JP, Johansen JD.

Contact Dermatitis. 2019 Feb;80(2):77-85. doi: 10.1111/cod.13119. Epub 2018 Oct 29.

PMID:
30370565
36.

The good, the bad and the malignant.

Egeberg A.

Br J Dermatol. 2018 Oct;179(4):809-810. doi: 10.1111/bjd.17022. No abstract available.

PMID:
30318797
37.

Pregnancy complications, treatment characteristics and birth outcomes in women with atopic dermatitis in Denmark.

Hamann CR, Egeberg A, Wollenberg A, Gislason G, Skov L, Thyssen JP.

J Eur Acad Dermatol Venereol. 2019 Mar;33(3):577-587. doi: 10.1111/jdv.15256. Epub 2018 Oct 8.

PMID:
30242910
38.

Risk of first-time and recurrent depression in patients with psoriasis: a population-based cohort study.

Egeberg A, Thyssen JP, Wu JJ, Skov L.

Br J Dermatol. 2019 Jan;180(1):116-121. doi: 10.1111/bjd.17208. Epub 2018 Nov 19.

PMID:
30229872
39.

Atopic dermatitis and cancer in solid organs: a systematic review and meta-analysis.

Halling-Overgaard AS, Ravnborg N, Silverberg JI, Egeberg A, Thyssen JP.

J Eur Acad Dermatol Venereol. 2019 Feb;33(2):e81-e82. doi: 10.1111/jdv.15230. Epub 2018 Sep 23. No abstract available.

PMID:
30169889
40.

Incidence and Risk of Inflammatory Bowel Disease in Patients with Psoriasis-A Nationwide 20-Year Cohort Study.

Egeberg A, Thyssen JP, Burisch J, Colombel JF.

J Invest Dermatol. 2019 Feb;139(2):316-323. doi: 10.1016/j.jid.2018.07.029. Epub 2018 Aug 18.

PMID:
30130618
41.

Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis.

Rønnstad ATM, Halling-Overgaard AS, Hamann CR, Skov L, Egeberg A, Thyssen JP.

J Am Acad Dermatol. 2018 Sep;79(3):448-456.e30. doi: 10.1016/j.jaad.2018.03.017.

PMID:
30119868
42.

Pyridine-based low-temperature synthesis of CoN, Ni3N and Cu3N nanoparticles.

Egeberg A, Warmuth L, Riegsinger S, Gerthsen D, Feldmann C.

Chem Commun (Camb). 2018 Aug 30;54(71):9957-9960. doi: 10.1039/c8cc04893b.

PMID:
30116819
43.

Cardiovascular disease and atopic dermatitis: epidemiological strengths and limitations.

Thyssen JP, Egeberg A.

Br J Dermatol. 2018 Oct;179(4):1014-1015. doi: 10.1111/bjd.16939. Epub 2018 Aug 29. No abstract available.

PMID:
29971775
44.

Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies.

Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ, Thyssen JP, Egeberg A.

J Am Acad Dermatol. 2019 Jan;80(1):251-265.e19. doi: 10.1016/j.jaad.2018.06.027. Epub 2018 Jun 19.

PMID:
29928910
45.

Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study.

Hesselvig JH, Egeberg A, Kofoed K, Gislason G, Dreyer L.

Br J Dermatol. 2018 Nov;179(5):1095-1101. doi: 10.1111/bjd.16831. Epub 2018 Sep 5.

PMID:
29885269
46.

Drug survival of secukinumab for moderate-to-severe plaque psoriasis: reply from authors.

Egeberg A, Skov L.

Br J Dermatol. 2018 Jul;179(1):222-223. doi: 10.1111/bjd.16690. Epub 2018 May 7. No abstract available.

PMID:
29736995
47.

Drug survival of secukinumab for psoriasis in a real-world setting.

Lee EB, Amin M, Egeberg A, Wu JJ.

J Dermatolog Treat. 2019 Mar;30(2):150-151. doi: 10.1080/09546634.2018.1473838. Epub 2018 May 24. No abstract available.

PMID:
29733240
48.

Adverse events associated with apremilast use and withdrawal for psoriasis in a real-world setting.

Lee EB, Amin M, Egeberg A, Wu JJ.

J Eur Acad Dermatol Venereol. 2018 Oct;32(10):e393-e394. doi: 10.1111/jdv.15061. Epub 2018 Jul 20. No abstract available.

PMID:
29730885
49.

The effects of season and weather on healthcare utilization among patients with atopic dermatitis.

Hamann CR, Andersen YMF, Engebretsen KA, Skov L, Silverberg JI, Egeberg A, Thyssen JP.

J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1745-1753. doi: 10.1111/jdv.15023. Epub 2018 May 31.

PMID:
29706020
50.

Incidence of pediatric atopic dermatitis following thymectomy: A Danish register study.

Thyssen JP, Andersen YMF, Zhang H, Gislason G, Skov L, Egeberg A.

Allergy. 2018 Aug;73(8):1741-1743. doi: 10.1111/all.13457. Epub 2018 May 16. No abstract available.

PMID:
29660152

Supplemental Content

Loading ...
Support Center